Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Mersana Therapeutics, Takeda Expand Partnership
Monday, February 08, 2016
Mersana to receive $40 million upfront, $20 million upon IND clearance and up to $20 million in equity investment.

Counting Cancer-busting Oxygen Molecules
Monday, February 08, 2016
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.

Therapeutic Approach Gives Hope for Multiple Myeloma
Monday, February 08, 2016
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.

Protein Protects Against Flu in Mice
Monday, February 08, 2016
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.

Crowdfunding the Fight Against Cancer
Monday, February 08, 2016
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?

Affinivax Secures Funding for Pneumococcal Vaccine
Monday, February 08, 2016
Company achieves key milestones and additional $2.5 million from the Gates Foundation.

Lonza to Build Capabilities for Drug Product Development
Friday, February 05, 2016
Company to Develop Drug Product Services for Customers by building its capabilities step-wise over the coming years.

Natural Protein Points to New Inflammation Treatment
Friday, February 05, 2016
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.

ImmunoGen, Merck Establish Collaboration
Friday, February 05, 2016
ImmunoGen, a biotechnology company that develops novel anticancer therapeutics using its ADC technology, and Merck, known as MSD outside the United States and Canada, announced have that they have entered into a clinical research collaboration.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 1787
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!